Regulatory Quality Pharmatech offers end-to-end regulatory navigation with FDA and international health authority guidance, robust quality management systems, risk assessments, CAPAs, and training, positioning them as a single partner from development through commercialization. Sales angle: approach sponsors seeking accelerated regulatory readiness and compliant product launches, emphasizing reduced risk and time-to-market.

PCM Manufacturing Backed by USP and a strategic alliance, Pharmatech brings continuous manufacturing expertise and readiness for scale-up, including process development, transfer, and validation; the upcoming Novo Nordisk raw-material facility signals growing demand for PCM capabilities. Sales angle: target manufacturers facing downtime, shortages, or pricing pressure who need scalable, compliant PCM solutions.

Growth Enablement With a mid-market footprint and plans to grow headcount, Pharmatech can offer scalable outsourcing of regulatory, quality, and program management services to support rapid expansion without internal hires. Sales angle: propose modular service packages for startups to mid-sized pharma sponsors.

Lifecycle Bundles The company's breadth across product and process development, QA/QMS, risk management, CAPA, and training enables bundled lifecycle engagements from early development to market entry, reducing time-to-market and regulatory risk. Sales angle: present bundled offerings with milestones and ROI to streamline procurement.

USP Network As a USP subsidiary and partner, Pharmatech can leverage its credibility, regulatory expertise, and PCM capabilities to win engagements with drug sponsors facing shortages and supply-chain challenges, with opportunities to cross-sell across USP client networks. Sales angle: leverage USP relationships to accelerate client acquisition and cross-sell PCM and quality services.